Anthem Biosciences Files ₹3,395 Crore IPO Draft Papers
December 31, 2024 19:04
Anthem Biosciences, a CRDMO specializing in drug discovery, development and manufacturing, has filed draft papers with Sebi for a ₹3,395 crore IPO. The IPO is an offer for sale by promoters,...